404 related articles for article (PubMed ID: 7554050)
1. DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays.
Venkatachalam S; Denissenko M; Wani AA
Carcinogenesis; 1995 Sep; 16(9):2029-36. PubMed ID: 7554050
[TBL] [Abstract][Full Text] [Related]
2. Repair analysis of promutagenic (+)-anti-BPDE DNA adduct in transcriptionally active sequences of plasmid DNA in Escherichia coli.
Musarrat J; Arezina-Wilson J; Venkatachalam S; Wani AA
Biochim Biophys Acta; 1997 Mar; 1351(1-2):203-12. PubMed ID: 9116034
[TBL] [Abstract][Full Text] [Related]
3. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
4. The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo.
Van Schooten FJ; Kriek E; Steenwinkel MJ; Noteborn HP; Hillebrand MJ; Van Leeuwen FE
Carcinogenesis; 1987 Sep; 8(9):1263-9. PubMed ID: 3113753
[TBL] [Abstract][Full Text] [Related]
5. Differences in the rate of DNA adduct removal and the efficiency of mutagenesis for two benzo[a]pyrene diol epoxides in CHO cells.
MacLeod MC; Daylong A; Adair G; Humphrey RM
Mutat Res; 1991 Dec; 261(4):267-79. PubMed ID: 1722282
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells.
Lloyd DR; Hanawalt PC
Cancer Res; 2000 Feb; 60(3):517-21. PubMed ID: 10676627
[TBL] [Abstract][Full Text] [Related]
7. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
8. BPDE-induced genotoxicity: relationship between DNA adducts, mutagenicity in the in vitro PIG-A assay, and the transcriptional response to DNA damage in TK6 cells.
Piberger AL; Krüger CT; Strauch BM; Schneider B; Hartwig A
Arch Toxicol; 2018 Jan; 92(1):541-551. PubMed ID: 28593498
[TBL] [Abstract][Full Text] [Related]
9. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
[TBL] [Abstract][Full Text] [Related]
10. Differential recognition of stereochemically defined base adducts by antibodies against anti-benzo[a]pyrene diol-epoxide-modified DNA.
Venkatachalam S; Wani AA
Carcinogenesis; 1994 Apr; 15(4):565-72. PubMed ID: 8149464
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
12. Determination of stereospecificity of benzo[a]pyrene diolepoxide-DNA antisera with site-specifically modified oligonucleotides.
Hsu TM; Liu TM; Amin S; Geacintov NE; Santella RM
Carcinogenesis; 1995 Sep; 16(9):2263-5. PubMed ID: 7554088
[TBL] [Abstract][Full Text] [Related]
13. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
14. Site-specific induction and repair of benzo[a]pyrene diol epoxide DNA damage in human H-ras protooncogene as revealed by restriction cleavage inhibition.
Denissenko MF; Venkatachalam S; Ma YH; Wani AA
Mutat Res; 1996 May; 363(1):27-42. PubMed ID: 8632776
[TBL] [Abstract][Full Text] [Related]
15. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of benzo[a]pyrene diol-epoxide (BPDE)-induced comet assay effects.
Bausinger J; Schütz P; Piberger AL; Speit G
Mutagenesis; 2016 Mar; 31(2):161-9. PubMed ID: 26346062
[TBL] [Abstract][Full Text] [Related]
17. Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra.
Wei D; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2204-8. PubMed ID: 7892248
[TBL] [Abstract][Full Text] [Related]
18. Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells.
Shen S; Lee J; Cullen WR; Le XC; Weinfeld M
Chem Res Toxicol; 2009 Feb; 22(2):382-90. PubMed ID: 19146383
[TBL] [Abstract][Full Text] [Related]
19. Quantitative study of stereospecific binding of monoclonal antibody to anti-benzo(a)pyrene diol epoxide-N(2)-dG adducts by capillary electrophoresis immunoassay.
Wang C; Li T; Wang Z; Feng F; Wang H
J Chromatogr A; 2010 Apr; 1217(15):2254-61. PubMed ID: 20223464
[TBL] [Abstract][Full Text] [Related]
20. Low absolute mutagenic efficiency but high cytotoxicity of a non-bay region diol epoxide derived from benzo[a]pyrene.
MacLeod MC; Adair G; Daylong A; Lew L; Humphrey RM
Mutat Res; 1991 Dec; 261(4):281-93. PubMed ID: 1722283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
